{
    "organizations": [],
    "uuid": "6d37ebe37f34e7bb1666eb2fb9b0e2d73cfb238c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-heat-biologics-gets-recommendation/brief-heat-biologics-gets-recommendation-to-continue-patient-enrollment-of-ongoing-phase-2-clinical-trial-idUSFWN1QA118",
    "ord_in_thread": 0,
    "title": "BRIEF-Heat Biologics Gets Recommendation To Continue Patient Enrollment Of Ongoing Phase 2 Clinical Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Heat Biologics Inc:\n* SAYS GOT INDEPENDENT DMC RECOMMENDATION TO CONTINUE PATIENT ENROLLMENT OF ONGOING PHASE 2 CLINICAL TRIAL FOR HS-110 AND NIVOLUMABâ€‹ Source text: ( bit.ly/2BG2kXt ) Further company coverage:\n ",
    "published": "2018-02-21T03:00:00.000+02:00",
    "crawled": "2018-02-21T21:43:55.061+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "heat",
        "biologics",
        "inc",
        "say",
        "got",
        "independent",
        "dmc",
        "recommendation",
        "continue",
        "patient",
        "enrollment",
        "ongoing",
        "phase",
        "clinical",
        "trial",
        "source",
        "text",
        "company",
        "coverage"
    ]
}